Protalix BioTherapeutics
PLX
#8866
Rank
โ‚น13.07 B
Marketcap
โ‚น162.54
Share price
2.26%
Change (1 day)
0.72%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.80. In 2024 the company made an earnings per share (EPS) of โ‚น3.59 a decrease over its 2023 EPS that were of โ‚น10.78.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-51.42%
2024โ‚น3.59-66.67%
2023โ‚น10.78-138.71%
2022-โ‚น27.84-50%
2021-โ‚น55.68181.82%
2020-โ‚น19.76-82.11%
2019-โ‚น110.46-31.67%
2018-โ‚น161.64-72.31%
2017-โ‚น583.71124.14%
2016-โ‚น260.42-147.54%
2015โ‚น547.79-290.63%
2014-โ‚น287.366.67%
2013-โ‚น269.40130.77%
2012-โ‚น116.74-69.77%
2011-โ‚น386.1419.44%
2010-โ‚น323.28-12.2%
2009-โ‚น368.1836.67%
2008-โ‚น269.40-37.5%
2007-โ‚น431.0450%
2006-โ‚น287.363.23%
2005-โ‚น278.38138.46%
2004-โ‚น116.74-74%
2003-โ‚น449.01-0%
2002-โ‚น449.01-50%
2001-โ‚น898.01233.33%
2000-โ‚น269.40-84.21%
1999-โ‚น1,706-24%
1998-โ‚น2,245-600%
1997โ‚น449.01-16.67%
1996โ‚น538.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-โ‚น9.88-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น387.04 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.46 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.57 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel